;

:

–

Ogami K, Hadzopoulou-Cladaras M, Cladaras C, Zannis VI. Promoter elements and factors required for hepatic and intestinal transcription of the human Ap

III gene. J Biol Chem.

;

:

–

O’Brien RM, Bonovich MT, Forest CD, Granner DK. Signal transduc- tion convergence: phorbol esters and insulin inhibit phospoenolpyruvate carboxykinase gene transcription through the same

-base-pair se- quence. Proc Natl Acad Sci USA.

;

:

–

Chen M, Breslow JL, Li W, Leff T. Transcriptional regulation of the ap

-III gene by insulin in diabetic mice: correlation with changes in plasma triglyceride levels. J Lipid Res.

;

:

–

Li WW, Leff T Regulation of apolipoprotein CIII gene transcription by insulin: characterization of an insulin response element in the CIII promoter. Circulation.

;

:

–

Li WW, Dammerman MM, Smith JD, Metzger S, Breslow JL, Leff T. Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceri- demia. J Clin Invest.

;

:

–

Haffner SM, Valdez RA, Hazuda HP, Mitchell B, Morales PA, Stern MP. Prospective anaysis of the insulin-resistance syndrome (syndrome X). Diabetes.

;

:

–

Dammerman M, Breslow JL. Genetic basis of lipoprotein disorders. Circulation.

;

:

–

Baron AD. Hemodynamic actions of insulin. Am J Physiol.

;

: E

–E

Reaven GM, Lithell H, Landsberg L. Hypertension and associated

GM, Lithell H, Landsberg L. Hypertension and associated